Horizon Pharma Inc. (HZNP: Quote) announced that it intends to offer and sell units in an underwritten public offering, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock.
Horizon also expects to grant the underwriters a 30-day option to purchase additional shares of its common stock and warrants to purchase shares of its common stock to cover overallotments, if any. All of the units in the offering are being offered by Horizon.
Cowen and Company, LLC, JMP Securities LLC and Stifel Nicolaus Weisel are acting as joint book-running managers for the offering.
Click here to receive FREE breaking news email alerts for Horizon Pharma Inc and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com